Navigation Links
Arcturus Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference
Date:12/1/2014

SAN DIEGO, Dec. 1, 2014 /PRNewswire/ -- Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing orphan diseases, today announced that Joseph E. Payne, President & CEO, will present at the 26th Annual Piper Jaffray Healthcare Conference being held on December 2-3 at New York Palace hotel in NY. The company presentation will take place on December 2nd, at 3:30 PM EST.

"We are pleased to provide a corporate overview highlighting the significant progress we have made with our leading UNA Oligomer™ chemistry and LUNAR™ delivery technologies, as well as our growing pipeline of RNA medicines," said Joseph E. Payne, President & CEO of Arcturus Therapeutics.

About Transthyretin (TTR)-Mediated Amyloidosis

Transthyretin (TTR)-mediated amyloidosis is a genetically mediated fatal disease caused by mutations in the TTR gene. Mutated TTR, which is mainly synthesized in the liver, causes errant amyloid proteins to aggregate and deposit, destroying body organs and tissue, such as the peripheral nerves and heart. TTR-mediated cardiomyopathy (FAC) affects approximately 40,000 people with the mean survival of ~2.5 years. TTR-mediated polyneuropathy (FAP) affects at least 10,000 people. There is a substantial unmet need for effective medicines for patients suffering from TTR-mediated diseases.

About Arcturus Therapeutics, Inc.

Founded in 2013 and based in San Diego, Arcturus Therapeutics is focused on RNA medicines for the treatment of rare diseases. Arcturus has developed a novel, potent and safe RNA Therapeutics platform called LUNAR™, a proprietary lipid-enabled delivery system for RNA medicines including small interfering RNA, messenger RNA, antisense RNA, and microRNA oligotherapeutics. The company's UNA Oligomer™ chemistry technology and patent portfolio (34 patents, USPTO granted) enables the targeting of any gene in the human genome. For more information, visit www.ArcturusRx.com.

Logo - http://photos.prnewswire.com/prnh/20130531/MM24393LOGO


'/>"/>
SOURCE Arcturus Therapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Arcturus Therapeutics Acquires Cutting-Edge UNA Patent Estate from Marina Biotech
2. Arcturus Therapeutics, Inc. Announces an RNAi Therapeutic Targeting Transthyretin-mediated Amyloidosis as its Flagship Program
3. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
4. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
5. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
8. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
9. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
10. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
11. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2020)... ... ... September is National Ovarian Cancer Awareness Month. Ovarian cancer is the ... the female reproductive system. The American Cancer Society estimates that in 2020, about ... from this disease. Throughout the month of September, Women’s Excellence aims to increase ...
(Date:8/28/2020)... ... August 28, 2020 , ... Cano ... medical centers in Florida and San Antonio is happy to announce that it ... centers. , In this capacity he will serve as community advisor, advertising talent, ...
(Date:8/27/2020)... ... August 27, 2020 , ... The flu season is right round the corner and ... equipped with all the necessary measures before it begins to harbor its effects on us. ... it is leaving a huge impact on our lives. Hence it has become even more ...
Breaking Medicine Technology:
(Date:9/2/2020)... Pa. (PRWEB) , ... September 02, 2020 , ... ... of enterprise software for healthcare payers administering Medicare Advantage and Special Needs plans, ... Online presented by America’s Health Insurance Plans (AHIP). RAM is supporting the event ...
(Date:9/1/2020)... ... ... Feeding Matters , the first organization in the world dedicated to advancing ... announce that the U.S. Centers for Disease Control and Prevention (CDC) has officially approved ... the U.S. International Classification of Diseases (ICD ) on October 1, 2021. ...
(Date:8/31/2020)... ... August 31, 2020 , ... Cardiothoracic surgeons ... biomedical engineers from Carnegie Mellon University (CMU) to develop a new heart monitoring ... undergone open heart surgery. , The AGH/CMU team was recently awarded a “Trailblazer” ...
(Date:8/31/2020)... Miss. (PRWEB) , ... August 31, 2020 , ... ... (GCPP) recently donated 1,400 N95 face masks to medical first responders across the ... continued to make donations of personal protective equipment (PPE) medical centers , ...
(Date:8/31/2020)... ... August 31, 2020 , ... Colorado State University Global (CSU ... affordable online education – is proud to announce its new master’s degree in ... its kind in the nation, the 60-credit hour program is designed to provide ...
Breaking Medicine News(10 mins):